期刊文献+

氩氦冷冻胶质瘤细胞致敏树突状细胞诱导肿瘤杀伤效应的实验研究 被引量:1

Tumorieidal effect of dendritic cells pulsed with Ar-He cryoablation on glioma cells
原文传递
导出
摘要 目的探讨氩氦冷冻胶质瘤细胞冻融产物对C57BL/6小鼠骨髓源树突状细胞(DCs)成熟的影响.以及致敏DCs诱导肿瘤杀伤效应的作用机制。方法采用氩氦冷冻法冻融GL261胶质瘤细胞为实验组,只插入探针不冷冻为阴性对照组,冻融等量PBS为空白对照组,采用BCA法测定冻融产物蛋白浓度;体外诱导小鼠骨髓细胞为DCs,加入各组冻融产物后观察其形态学变化。流式细胞仪检测DCs表面CD80、CD86、MHC—I、MHC-Ⅱ的表达。ELISA检测其上清液中IL.12p70的含量;提取小鼠脾脏T细胞,与各组抗原致敏的DCs共培养后活化,流式细胞仪检测活化T细胞CD3、CD4、CD8的表达;以GL261细胞为靶细胞,以活化的T细胞即细胞毒性T细胞(CTLsl作为效应细胞,效靶比分别为10:1、50:1和100:1时CCK-8法检测CTLs对GL261的杀伤率。结果实验组冻融产物即肿瘤抗原浓度[(1071±240.94)μg/mE]高于阴性对照组[(91.42±55.75)μg/mL]及空白对照组(0Ixg/mL),差异有统计学意义(JD〈O.05);实验组DCs有典型成熟DCs形态,表型CD80、CD86、MHC-I、MHC—II的表达率及IL-12p70分泌量高于阴性对照组及空白对照组,差异有统计学意义(P〈0.05);实验组CD80细胞表达率高,CD4+T细胞表达率低,与阴性对照组及空白对照组相比差异有统计学意义(p〈0.05);不同效靶比时实验组CTLs对GL261细胞的杀伤率显著高于阴性对照组及空白对照组,差异有统计学意义(P〈0.05)。结论氩氦冷冻胶质瘤细胞可获取大量肿瘤抗原并促进DCs成熟,冻融产物致敏DCs后可有效负载肿瘤抗原产生抗肿瘤效应,其机制与DCs表面分子CD80、CD86、MHC-I、MHC-Ⅱ的表达上调并诱导T细胞转化为CTLs有关。 Objective To explore the effect of Ar-He cryoahlation on maturation of bone marrow-derived dendritic cells (BMDCs) in C57BL/6 mouse, and the mechanism of sensitized dendritic cells (DCs) induced tumor killing effect. Methods Ar-He cryoablation ofGL261 glioma cells was used as experimental group, only inserting probe to GL261 glioma cells as negative control group and At-He cryoablation on the same amount of PBS as blank control group. The protein concentration of fi'eezing and thawing products was measured. DCs were induced fi'om BMDCs in vitro, and after tumor cell lysate was added, morphological characteristics of DCs were observed. The expressions of surface markers CD80, CD86, major histocompatibility complex-I (MHC-I) and MHC-II were analyzed by flow cytometry. The IL-12pT0 concentration in the supernatants was detected by enzyme-linked immunosorbent assay (ELISA). T cells were extracted and co-cultured with DCs, and then, the expressions of T cell phenotypes CD3, CD4 and CD8 were analyzed by flow cytometry. The killing rate ofT cells (choosing from sensitized DCs) to GL261 glioma cells was detected using CCK-8 method at different effect-target ratios (10:1, 50:1 and 100:1). Results The protein concentration of the experimental group ([1071±240.94] μg/mL) was higher than that of negative control group(J91.42±55.75]μg/mL) and blank control group (0μg/mL, P〈0.05). The experimental group showed typical characteristics of mature DCs, and the expressions of DCs phenotypes CDS0, CD86, MHC-I and MHC-II were higher than those in the negative control group and blank control group (P〈0.05); IL-12p70 secreted by experimental group DCs was higher than that by control group (P〈0.05). There were significantly more CDS+ T cells and less CD4+ T cells in the experimental group than negative control group and blank control group (P〈0.05). The killing rate of CTLs to GL261 glioma cells in the experimental group was significantly higher than that in the
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2013年第12期1228-1233,共6页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81172416) 国家临床重点建设专科资助项目
关键词 氩氦冷冻 神经胶质瘤 树突状细胞 细胞毒性T细胞 Ar-He cryoablation Glioma Dendritic cell Cytotoxic T lymphocyte
  • 相关文献

参考文献15

  • 1Lasky JR, Panosyan EH, Plant A, et al. Autologous Tumor Lysate-pulsed Dendritic Cell Immunotherapy for Pediatric Patients with Newly Diagnosed or Recurrent High-grade Gliomas [J]. Anticancer Res, 2013, 33(5):2047-2056. 被引量:1
  • 2Tyrinova TV, Leplina OY, Mishinov SV, et al. Cytotoxic activity of ex-vivo generated IFNalpha-induced monocyte-derived dendritic cells in brain glioma patients[J]. Cell Immunol, 2013, 284(1-2): 146-153. 被引量:1
  • 3Matin SF, Sharma P, Gill IS, et al. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model[J]. J Urol, 2010, 183(1):333-338. 被引量:1
  • 4孔繁宏,秦立东.氩氦刀靶向冷冻联合全身化疗治疗中晚期非小细胞肺癌的临床研究[J].中华肿瘤防治杂志,2011,18(14):1125-1126. 被引量:7
  • 5Gilbert MR, Gonzalez J, Hunter K, et al. A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma [J]. Neuro Oncol, 2010, 12(11): 1167-1172. 被引量:1
  • 6张世忠,张积仁,徐如祥,徐强,汪森明.立体定向引导氩氦刀靶向冷冻治疗脑胶质瘤[J].中国微侵袭神经外科杂志,2000,5(2):103-106. 被引量:17
  • 7苏道庆,卢国辉,胡丽娟,王保安,李明,何骁征,姜晓丹,柯以铨,张世忠.胶质瘤氩氦冻融产物负载树突状细胞对颅内胶质瘤大鼠的免疫治疗研究[J].中华神经医学杂志,2012,11(4):342-346. 被引量:3
  • 8Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses[J]. Cryobiology, 2009, 58(1): 1-11. 被引量:1
  • 9Ismail M, Morgan R, Harrington K, et al. Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model[J]. Cryobiology, 2010, 61 (3): 268-274. 被引量:1
  • 10Yamanaka R. Cell- and peptide-based immunotherapeutic approaches for glioma[J]. Trends Mol Med, 2008, 14(5):228-235. 被引量:1

二级参考文献38

  • 1张积仁.Cryocare氩氦靶向肿瘤治疗技术[J].生物医学工程研究,2005,24(2):128-132. 被引量:25
  • 2王煜,雷霆,牛洪泉,董震,董芳永,柳再明,薛德麟.树突状细胞瘤内注射和化疗联合治疗脑胶质瘤的实验研究[J].中华神经外科杂志,2006,22(3):184-186. 被引量:11
  • 3谢立旗,刘健,刘丽娜,郑卫权.CT引导氩氦刀冷冻治疗肺癌[J].实用医药杂志,2007,24(3):310-311. 被引量:3
  • 4刘英华,王忠诚,石祥恩,张懋植.恶性胶质瘤施行嘧啶亚硝脲化学治疗临床观察[J].中华神经外科杂志,1997,13(1):28-30. 被引量:22
  • 5Kim Y H,Kim J S,choi Y H,et al. Phase Ⅱ study of docetaxel and cisplatin chemotherapy in metastatic or unresectable local ized non-small-cell lung cancer[J]. Int J clin oncol,2002,7(2) 117 -119. 被引量:1
  • 6Markey K A, Banovic T, Kuns R D, et al. Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation [J]. Blood, 2009, 113 (22) : 5644-5649. 被引量:1
  • 7Perry J A, Rush A, Wilson R J, et al. Dendritic cells from malaria-infected mice are fully functional APC [J]. J Immunol, 2004, 172(1) :475-482. 被引量:1
  • 8Kim J, Kim Y M, Jeoung D I, et al. Human follicular dendritic ceils promote the APC capability of B cells by enhancing CD86 expression levels [J]. Cell Immunol, 2012, 273(2):109-114. 被引量:1
  • 9Baleeiro R B, Bergami-Santos P C, Tomiyoshi M Y, et al. Expression of a dendritic cell maturation marker CD83 on tumor cells from lung cancer patients and several human tumor cell lines: is there a biological meaning behind it [J]? Cancer Immunol Immunother, 2008, 57(2):265-270. 被引量:1
  • 10Chang C C, Wright A, Punnonen J. Monocyte-derived CD1a+ and CDla-dendritic cell subsets differ in their cytokine production profiles,susceptibilities to transfection,and capacities to direct Th cell differentiation[J]. J Immunol, 2000, 165 (7) : 3584-3591. 被引量:1

共引文献25

同被引文献17

  • 1Corfield AP. Mucins: a biologically relevant glycan barrier in mucosal protection [J]. Biochim Biophys Acta, 2015, 1850 (1): 236-252. 被引量:1
  • 2Garcia-Martin F, Matsushita T, Hinou H, et al. Fast epitope mapping for the anti-MUC1 monoelonal antibody by combining aone-bead-one-glycopeptide library and a microarray platform [J]. Chemistry, 2014, 20(48): 15891-15892. 被引量:1
  • 3Baskar R, Lee KA, Yeo IL et al. Cancer and radiation therapy: current advances and future directions[J]. Int J Med Sci, 2012, 9(3): 193-199. 被引量:1
  • 4Wang B, Wang Q, Wang Z, et al. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells[J]. Cancer Res, 2014, 74(20): 5746-5757. 被引量:1
  • 5Ahmed S, Pahwa P, Fields A, et al. Predictive factors of the use of systemic therapy in stage IV colorectal cancer: who gets chemotherapy[J]. Oncology, 2015, 88(5): 289-297. 被引量:1
  • 6Voloshin T, Voest EE, Shaked Y. The host immunological response to cancer therapy: An emerging concept in tumor biology[J]. Exp Cell Res, 2013, 319(11): 1687-1695. 被引量:1
  • 7Hammerstrom AE, Cauley DH, Atkinson B J, et al. Cancer immunotherapy: sipuleucel-T and beyond [J]. Pharmacotherapy, 2011, 31(8): 813-828. 被引量:1
  • 8Bilusic M, Heery C, Madan RA. Immunotherapy in prostate cancer: emerging strategies against a formidable foe[J]. Vaccine, 2011, 29 (38): 6485-6497. 被引量:1
  • 9Pardoll D, Drake C. Immunotherapy earns its spot in the ranks of cancer therapy[J]. J Exp Med, 2012, 209(2): 201-209. 被引量:1
  • 10Ali A, Jafri RZ, Messonnier N, et al. Global practices of meningococcal vaccine use and impact on invasive disease [J]. Pathog Glob Health, 2014, 108(1):11-20. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部